135 related articles for article (PubMed ID: 27648370)
21. Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer.
Iqbal S; Vishnubhatla S; Raina V; Sharma S; Gogia A; Deo SS; Mathur S; Shukla NK
Springerplus; 2015; 4():265. PubMed ID: 26090312
[TBL] [Abstract][Full Text] [Related]
22. Cell-free DNA in human follicular fluid as a biomarker of embryo quality.
Scalici E; Traver S; Molinari N; Mullet T; Monforte M; Vintejoux E; Hamamah S
Hum Reprod; 2014 Dec; 29(12):2661-9. PubMed ID: 25267787
[TBL] [Abstract][Full Text] [Related]
23. Circulating cell-free DNA in serum as a biomarker of colorectal cancer.
da Silva Filho BF; Gurgel AP; Neto MÁ; de Azevedo DA; de Freitas AC; Silva Neto Jda C; Silva LA
J Clin Pathol; 2013 Sep; 66(9):775-8. PubMed ID: 23833048
[TBL] [Abstract][Full Text] [Related]
24. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
Madhavan D; Wallwiener M; Bents K; Zucknick M; Nees J; Schott S; Cuk K; Riethdorf S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Surowy H; Burwinkel B
Breast Cancer Res Treat; 2014 Jul; 146(1):163-74. PubMed ID: 24838941
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cell-free DNA as a biomarker for pancreatic malignancies.
Sikora K; Bedin C; Vicentini C; Malpeli G; D'Angelo E; Sperandio N; Lawlor RT; Bassi C; Tortora G; Nitti D; Agostini M; Fassan M; Scarpa A
Int J Biol Markers; 2015 Feb; 30(1):e136-41. PubMed ID: 24832178
[TBL] [Abstract][Full Text] [Related]
26. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
[TBL] [Abstract][Full Text] [Related]
27. Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.
Desai A; Kallianpur S; Mani A; Tijare MS; Khan S; Jain M; Mathur V; Ahuja R; Saxena V
Gulf J Oncolog; 2018 May; 1(27):11-17. PubMed ID: 30145546
[TBL] [Abstract][Full Text] [Related]
28. Decreased serum cell-free DNA levels in rheumatoid arthritis.
Dunaeva M; Buddingh' BC; Toes RE; Luime JJ; Lubberts E; Pruijn GJ
Auto Immun Highlights; 2015 Aug; 6(1-2):23-30. PubMed ID: 26113482
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
[TBL] [Abstract][Full Text] [Related]
30. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
31. Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma.
Chen H; Sun LY; Zheng HQ; Zhang QF; Jin XM
Pathology; 2012 Jun; 44(4):318-324. PubMed ID: 28193336
[TBL] [Abstract][Full Text] [Related]
32. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
Yu Z; Qin S; Wang H
J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
[TBL] [Abstract][Full Text] [Related]
33. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.
Lapin M; Oltedal S; Tjensvoll K; Buhl T; Smaaland R; Garresori H; Javle M; Glenjen NI; Abelseth BK; Gilje B; Nordgård O
J Transl Med; 2018 Nov; 16(1):300. PubMed ID: 30400802
[TBL] [Abstract][Full Text] [Related]
34. Cell-Free DNA as a New Biomarker of IVF Success, Independent of Any Infertility Factor, Including Endometriosis.
Casteleiro Alves MM; Oliani L; Almeida M; Cardoso HJ; Oliani AH; Breitenfeld L; Ramalhinho AC
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673018
[TBL] [Abstract][Full Text] [Related]
35. Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma.
El-Gayar D; El-Abd N; Hassan N; Ali R
Asian Pac J Cancer Prev; 2016; 17(3):939-44. PubMed ID: 27039817
[TBL] [Abstract][Full Text] [Related]
36. Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer.
Waki K; Yokomizo K; Kawano K; Tsuda N; Komatsu N; Yamada A
Mol Clin Oncol; 2021 Feb; 14(2):29. PubMed ID: 33414910
[TBL] [Abstract][Full Text] [Related]
37. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.
Farrell JJ; Toste P; Wu N; Li L; Wong J; Malkhassian D; Tran LM; Wu X; Li X; Dawson D; Wu H; Donahue TR
Am J Gastroenterol; 2013 Aug; 108(8):1352-9. PubMed ID: 23752880
[TBL] [Abstract][Full Text] [Related]
38. Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer.
Hussein NA; Mohamed SN; Ahmed MA
Appl Biochem Biotechnol; 2019 Mar; 187(3):1028-1045. PubMed ID: 30151636
[TBL] [Abstract][Full Text] [Related]
39. Assessment of circulating serum DNA integrity in colorectal cancer patients.
Yörüker EE; Özgür E; Keskin M; Dalay N; Holdenrieder S; Gezer U
Anticancer Res; 2015 Apr; 35(4):2435-40. PubMed ID: 25862911
[TBL] [Abstract][Full Text] [Related]
40. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
